![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/10731094-596277381-9e99fbb8-cc4a-11e6-91dc-0b1813f59513-100x53.jpeg)
Cryoport Reports Second Quarter 2024 Financial Results
Revenue improved sequentially across all businesses Commercial Cell & Gene Therapy revenue increased 51% year-over-year and 20% sequentially A record total of 684 global clinical trials supported as of June 30, 2024 Cost reduction initiatives …